QIAGEN NV (QGEN)
QIAGEN Market Cap : 7.635B for June 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 7.635B |
| June 09, 2026 | 7.786B |
| June 08, 2026 | 7.472B |
| June 05, 2026 | 7.565B |
| June 04, 2026 | 7.747B |
| June 03, 2026 | 7.518B |
| June 02, 2026 | 7.361B |
| June 01, 2026 | 7.462B |
| May 29, 2026 | 7.547B |
| May 28, 2026 | 7.557B |
| May 27, 2026 | 7.443B |
| May 26, 2026 | 7.321B |
| May 22, 2026 | 7.245B |
| May 21, 2026 | 7.187B |
| May 20, 2026 | 7.229B |
| May 19, 2026 | 7.053B |
| May 18, 2026 | 6.959B |
| May 15, 2026 | 6.794B |
| May 14, 2026 | 6.858B |
| May 13, 2026 | 6.736B |
| May 12, 2026 | 6.942B |
| May 11, 2026 | 6.722B |
| May 08, 2026 | 6.806B |
| May 07, 2026 | 6.903B |
| May 06, 2026 | 7.095B |
| Date | Value |
|---|---|
| May 05, 2026 | 7.004B |
| May 04, 2026 | 6.996B |
| May 01, 2026 | 7.055B |
| April 30, 2026 | 7.123B |
| April 29, 2026 | 6.924B |
| April 28, 2026 | 7.008B |
| April 27, 2026 | 7.847B |
| April 24, 2026 | 7.912B |
| April 23, 2026 | 7.822B |
| April 22, 2026 | 8.234B |
| April 21, 2026 | 8.261B |
| April 20, 2026 | 8.454B |
| April 17, 2026 | 8.495B |
| April 16, 2026 | 8.438B |
| April 15, 2026 | 8.578B |
| April 14, 2026 | 8.603B |
| April 13, 2026 | 8.633B |
| April 10, 2026 | 8.423B |
| April 09, 2026 | 8.448B |
| April 08, 2026 | 8.502B |
| April 07, 2026 | 8.267B |
| April 06, 2026 | 8.401B |
| April 02, 2026 | 8.452B |
| April 01, 2026 | 8.318B |
| March 31, 2026 | 8.248B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Thermo Fisher Scientific, Inc. | 179.14B |
| Illumina, Inc. | 24.70B |
| Agilent Technologies, Inc. | 37.15B |
| Bruker Corp. | 8.360B |
| Bio-Rad Laboratories, Inc. | 7.807B |
Market Cap Related Metrics
| PE Ratio | 19.12 |
| PS Ratio | 3.666 |
| PEG Ratio | 0.0616 |
| Price to Book Value | 2.292 |
| Price to Free Cash Flow | 19.05 |
| Price | 37.02 |
| Earnings Yield | 5.23% |
| PEGY Ratio | 0.0596 |
| Operating PE Ratio | 15.02 |
| Normalized PE Ratio | 16.80 |